Show
Sort by
-
- Journal Article
- A1
- open access
Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma
-
- Journal Article
- A1
- open access
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
-
- Journal Article
- A1
- open access
MEIS2 is an adrenergic core regulatory transcription factor involved in early initiation of TH-MYCN-driven neuroblastoma formation
-
- Journal Article
- A1
- open access
From DNA copy number gains and tumor dependencies to novel therapeutic targets for high-risk neuroblastoma
-
- Journal Article
- A1
- open access
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children : a review